Skip to content

Investor Relations / Events & Presentations

Events & Presentations

Upcoming Events

There are currently no events to display.


For web links to papers supporting correlation between TG levels and cardiovascular risk, click here.

Title Date Documents

January 2020 Investor Presentation

Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk

Slides to Accompany Q3’19 Investor Call

ACC- Physician Panel Discussion Presentation

ACC- Physician Panel Discussion

Primary REDUCE-IT ™ Trial Results Presentation

REDUCE-IT Efficacy and Safety Results and Related Disclosures

Primary REDUCE-IT ™ Trial Presentation

Top Line Results - ANCHOR Trial

Top Line Results - MARINE Trial

Archived Events

Date Event Details
Summary Toggle Jan 15, 2020
1:30 PM EST


Summary Toggle Nov 21, 2019
8:40 AM GMT

Jefferies 2019 London Healthcare Conference

Summary Toggle Nov 18, 2019
4:30 PM EST

AHA Investor Webcast

Summary Toggle Nov 5, 2019
7:30 AM EST

Amarin Q3 Results Conference Call

Summary Toggle Sep 9, 2019
8:45 AM EDT

H.C. Wainwright 21st Annual Global Investment Conference

Summary Toggle Sep 4, 2019
2:15 PM EDT

Citi’s 14th Annual Biotech Conference

Summary Toggle Jul 31, 2019
7:30 AM EDT
Summary Toggle Jul 8, 2019
7:00 PM EDT

August 8th Conference Call

Summary Toggle Jun 25, 2019
11:20 AM EDT

2019 BMO Prescription For Success Healthcare Conference

Summary Toggle Jun 12, 2019
4:20 PM EDT

Goldman Sachs 40th Annual Global Healthcare Conference

Summary Toggle Jun 6, 2019
9:30 AM EDT

Jefferies 2019 Healthcare Conference

Summary Toggle May 1, 2019
7:30 AM EDT

Amarin Q1 Results Conference Call

Summary Toggle Mar 13, 2019 from 8:00 AM to 8:30 AM EDT

Cowen’s 39th Annual Health Care Conference

Summary Toggle Feb 28, 2019
9:30 AM EST

8th Annual SVB Leerink Global Healthcare Conference

Summary Toggle Feb 27, 2019
7:30 AM EST

Amarin Q4 Results Conference Call

Amarin Corporation